| Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: protection associated with mycobacterial antigen-specific CD4 … S Sharpe, A White, C Sarfas, L Sibley, F Gleeson, A McIntyre, R Basaraba, ... Tuberculosis 101, 174-190, 2016 | 135 | 2016 |
| Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 FJ Salguero, AD White, GS Slack, SA Fotheringham, KR Bewley, ... Nature Communications 12 (1), 1260, 2021 | 131 | 2021 |
| Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques AD White, L Sibley, MJ Dennis, K Gooch, G Betts, N Edwards, ... Clinical and Vaccine Immunology 20 (5), 663-672, 2013 | 123 | 2013 |
| Evaluation of the immunogenicity of Mycobacterium bovis BCG delivered by aerosol to the lungs of macaques AD White, C Sarfas, K West, LS Sibley, AS Wareham, S Clark, MJ Dennis, ... Clinical and Vaccine Immunology 22 (9), 992-1003, 2015 | 71 | 2015 |
| Plant‐derived recombinant immune complexes as self‐adjuvanting TB immunogens for mucosal boosting of BCG I Pepponi, GR Diogo, E Stylianou, CJ van Dolleweerd, PMW Drake, ... Plant biotechnology journal 12 (7), 840-850, 2014 | 53 | 2014 |
| Mucosal delivery of antigen‐coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice E Stylianou, GR Diogo, I Pepponi, C van Dolleweerd, MA Arias, C Locht, ... European Journal of Immunology 44 (2), 440-449, 2014 | 50 | 2014 |
| Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model L Sibley, R Reljic, DS Radford, JM Huang, HA Hong, RM Cranenburgh, ... FEMS microbiology letters 358 (2), 170-179, 2014 | 47 | 2014 |
| MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in … AD White, L Sibley, C Sarfas, A Morrison, J Gullick, S Clark, F Gleeson, ... npj Vaccines 6 (1), 4, 2021 | 42 | 2021 |
| Mucosal vaccination against tuberculosis using inert bioparticles R Reljic, L Sibley, JM Huang, I Pepponi, A Hoppe, HA Hong, SM Cutting Infection and immunity 81 (11), 4071-4080, 2013 | 39 | 2013 |
| Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques L Sibley, K Gooch, A Wareham, S Gray, A Chancellor, S Dowall, S Bate, ... Scientific reports 9 (1), 3340, 2019 | 35 | 2019 |
| An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques SA Sharpe, AD White, L Sibley, F Gleeson, GA Hall, RJ Basaraba, ... PLoS One 12 (3), e0171906, 2017 | 29 | 2017 |
| Route of delivery to the airway influences the distribution of pulmonary disease but not the outcome of Mycobacterium tuberculosis infection in rhesus macaques L Sibley, M Dennis, C Sarfas, A White, S Clark, F Gleeson, A McIntyre, ... Tuberculosis 96, 141-149, 2016 | 28 | 2016 |
| Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques AD White, C Sarfas, LS Sibley, J Gullick, S Clark, E Rayner, F Gleeson, ... Pharmaceutics 12 (5), 394, 2020 | 27 | 2020 |
| Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines SA Harris, A White, L Stockdale, R Tanner, L Sibley, C Sarfas, J Meyer, ... Tuberculosis 108, 99-105, 2018 | 26 | 2018 |
| Influence of aerosol delivered BCG vaccination on immunological and disease parameters following SARS-CoV-2 challenge in rhesus macaques AD White, L Sibley, C Sarfas, AL Morrison, K Bewley, C Churchward, ... Frontiers in Immunology 12, 801799, 2022 | 21 | 2022 |
| Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques KR Bewley, K Gooch, KM Thomas, S Longet, N Wiblin, L Hunter, K Chan, ... Science advances 7 (37), eabg7996, 2021 | 19 | 2021 |
| ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models T Lambe, AJ Spencer, KM Thomas, KE Gooch, S Thomas, AD White, ... Communications biology 4 (1), 915, 2021 | 19 | 2021 |
| One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model KE Gooch, TRF Smith, FJ Salguero, SA Fotheringham, RJ Watson, ... Vaccine 39 (34), 4885-4894, 2021 | 17 | 2021 |
| ELISPOT refinement using spot morphology for assessing host responses to tuberculosis LS Sibley, AD White, A Marriott, MJ Dennis, A Williams, PD Marsh, ... Cells 1 (1), 5-14, 2012 | 14 | 2012 |
| Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic TRW Tipton, Y Hall, JA Bore, A White, LS Sibley, C Sarfas, Y Yuki, ... Nature Communications 12 (1), 1153, 2021 | 13 | 2021 |
